<?xml version="1.0" encoding="UTF-8"?>
<p>Specific risk factors for developing COVID‐19 in IBD patients are yet to be determined. For lower respiratory tract infections with seasonal (non‐COVID‐19) coronavirus, risk factors in other immunocompromised patient groups have included age &gt;50 years, receipt of corticosteroids, lymphopenia and neutropenia.
 <xref rid="apt15779-bib-0026" ref-type="ref">
  <sup>26</sup>
 </xref>, 
 <xref rid="apt15779-bib-0040" ref-type="ref">
  <sup>40</sup>
 </xref> For IBD patients, the greatest risk factor for general immunosuppression and infections remains pharmacological.
 <xref rid="apt15779-bib-0041" ref-type="ref">
  <sup>41</sup>
 </xref>, 
 <xref rid="apt15779-bib-0042" ref-type="ref">
  <sup>42</sup>
 </xref> Nutritional status, co‐morbidities, age and disease activity also contribute.
 <xref rid="apt15779-bib-0042" ref-type="ref">
  <sup>42</sup>
 </xref>, 
 <xref rid="apt15779-bib-0043" ref-type="ref">
  <sup>43</sup>
 </xref> Of these, malnutrition (OR: 6.26 [95% CI: 1.20‐32.78])
 <xref rid="apt15779-bib-0041" ref-type="ref">
  <sup>41</sup>
 </xref>, 
 <xref rid="apt15779-bib-0042" ref-type="ref">
  <sup>42</sup>
 </xref> and disease activity (OR: 3.35 [95%CI: 1.23‐9.23, 
 <italic>P</italic> = 0.02])
 <xref rid="apt15779-bib-0044" ref-type="ref">
  <sup>44</sup>
 </xref> are significant nonpharmacological risk factors that are modifiable for infection and therefore nutritional support and medical treatment aiming for disease control should be optimised.
 <xref rid="apt15779-bib-0041" ref-type="ref">
  <sup>41</sup>
 </xref>, 
 <xref rid="apt15779-bib-0042" ref-type="ref">
  <sup>42</sup>
 </xref> Furthermore, low vitamin D levels are prevalent in IBD patients and may be associated with an increased risk and/or severity of influenza and COVID‐19.
 <xref rid="apt15779-bib-0045" ref-type="ref">
  <sup>45</sup>
 </xref>, 
 <xref rid="apt15779-bib-0046" ref-type="ref">
  <sup>46</sup>
 </xref> Vitamin D increases anti‐inflammatory cytokines and lowers viral replication, which in turn may reduce pro‐inflammatory cytokines that propagate lung injury and ARDS.
 <xref rid="apt15779-bib-0045" ref-type="ref">
  <sup>45</sup>
 </xref>, 
 <xref rid="apt15779-bib-0046" ref-type="ref">
  <sup>46</sup>
 </xref>, 
 <xref rid="apt15779-bib-0047" ref-type="ref">
  <sup>47</sup>
 </xref> Therefore assessment of vitamin D and supplementation when it is low is reasonable.
</p>
